- STOCKWATCH: Missing the point
- Outrage at Cancer Drugs Fund casualty list
- US Capitol Capsule: Fighting the uphill battle: Stakes high for drug makers
- 5 questions for MSD India's boss
COMMENT Other Informa Comment
- Profile: The ABPI's reimbursement director on Pfizer, his TicTac salary, and paper mache
- Scrip 100: Alcon's Jeff George, 'Google guys blew us away'